| C07AB02 |
Metoprolol |
Metoprolol Polpharma |
Prolonged release tablet |
50 |
mg |
28 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
150 |
mg |
- |
3.88 |
0.225 |
2.1 |
50% |
1.05 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48,I50.0,I50.1 |
КЦРР-1568/05.11.2012 г. Протокол 56/27.02.2014 |
02.05.2018 |
|
|
Активен |
1424 |
| C07AB02 |
Metoprolol |
Metoprolol Polpharma |
Prolonged release tablet |
200 |
mg |
28 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
150 |
mg |
- |
9.62 |
0.225 |
8.4 |
50% |
4.2 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48,I50.0,I50.1 |
КЦРР-1568/05.11.2012 г.Протокол 56/27.02.2014; НСР-19172/04.07.2019 |
02.08.2019 |
|
|
Заличен |
1426 |
| C07AB02 |
Metoprolol |
Metoprolol Polpharma |
Prolonged release tablet |
100 |
mg |
28 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
150 |
mg |
- |
7.09 |
0.225 |
4.2 |
50% |
2.1 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48,I50.0,I50.1 |
КЦРР-1568/05.11.2012 г.; Протокол 56/27.02.2014; НСР-19171/04.07.2019 |
02.08.2019 |
|
|
Заличен |
1425 |
| C07AB02 |
Metoprolol |
METOPROLOL STADA |
Tablet |
100 |
mg |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
4.78 |
0.225 |
4.5 |
50% |
2.25 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
№ 68/ 08.04.2010 |
02.05.2018 |
08.09.2012 |
|
Активен |
14 |
| C07AB02 |
Metoprolol |
METOPROLOL STADA |
Tablet |
50 |
mg |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
3.58 |
0.225 |
2.25 |
50% |
1.12 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
№ 68/ 08.04.2010 |
02.05.2018 |
08.09.2012 |
|
Активен |
12 |
| C07AB02 |
Metoprolol |
METOPROLOL STADA |
Tablet |
100 |
mg |
20 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
3.58 |
0.225 |
3 |
50% |
1.5 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
№ 68/ 08.04.2010 |
02.05.2018 |
08.09.2012 |
|
Активен |
13 |
| C07AB02 |
Metoprolol |
METOPROLOL STADA |
Tablet |
50 |
mg |
20 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
2.65 |
0.225 |
1.5 |
50% |
0.75 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
№ 68/ 08.04.2010 |
02.05.2018 |
08.09.2012 |
|
Активен |
11 |
| C07AB02 |
Metoprolol |
METOPROLOL STADA 200 RETARD |
Prolonged release tablet |
200 |
mg |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
11.33 |
0.225 |
9 |
50% |
4.5 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
№ 68/ 08.04.2010 |
02.05.2018 |
08.09.2012 |
|
Активен |
16 |
| C07AB02 |
Metoprolol |
METOPROLOL STADA 200 RETARD |
Prolonged release tablet |
200 |
mg |
20 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
8.21 |
0.225 |
6 |
50% |
3 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
№ 68/ 08.04.2010 |
02.05.2018 |
08.09.2012 |
|
Активен |
15 |
| C07AB02 |
Metoprolol |
Metoprol tartrate Accord |
Tablet |
50 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
150 |
mg |
- |
4.5 |
0.225 |
2.25 |
50% |
1.12 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
КЦРР-868/26.06.2012 г.; НСР-946/12.08.2013; НСР-16814/20.09.2018; НСР-19299/18.07.2019 |
02.09.2019 |
08.09.2012 |
|
Заличен |
1104 |
| C07AB02 |
Metoprolol |
Metoprol tartrate Accord |
Tablet |
100 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
150 |
mg |
- |
4.64 |
0.225 |
4.5 |
50% |
2.25 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
КЦРР-868/26.06.2012 г.; НСР-947/12.08.2013.; НСР-7213/09.10.2015. и КП-398/25.11.2015. |
02.05.2018 |
08.09.2012 |
|
Активен |
1105 |
| C07AB02 |
Metoprolol |
METOSTAD |
Prolonged release tablet |
100 |
mg |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
9.28 |
0.232 |
4.64 |
50% |
2.32 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48 |
№ 48/ 09.02.2010; НСР-2503/24.01.2014; НСР-15101/23.02.2018 |
02.04.2018 |
08.09.2012 |
|
Заличен |
2480 |
| C07AB02 |
Metoprolol |
METOSTAD |
Prolonged release tablet |
50 |
mg |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
6.71 |
0.232 |
2.32 |
50% |
1.16 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48,I50.0,I50.1 |
№ 48/ 09.02.2010; НСР-3455/30.04.2014; НСР-15101/23.02.2018 |
02.04.2018 |
08.09.2012 |
|
Заличен |
813 |
| C07AB02 |
Metoprolol |
METOSTAD |
Prolonged release tablet |
25 |
mg |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
4.48 |
0.232 |
1.16 |
50% |
0.58 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48,I50.0,I50.1 |
№ 48/ 09.02.2010; НСР-3455/30.04.2014; НСР-15101/23.02.2018 |
02.04.2018 |
08.09.2012 |
|
Заличен |
812 |
| C07AB02 |
Metoprolol |
Metostad CR |
Prolonged release tablet |
95 mg |
(съответстващ на 100mg metoprolol tartrate) |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
12.25 |
0.225 |
4.5 |
50% |
2.25 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48,I50.0,I50.1 |
НСР-12637/12.05.2017 |
02.05.2018 |
|
|
Активен |
15717 |
| C07AB02 |
Metoprolol |
Metostad CR |
Prolonged release tablet |
47.5 mg |
(съответстващ на 50mg metoprolol tartrate) |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
9.7 |
0.225 |
2.25 |
50% |
1.12 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48,I50.0,I50.1 |
НСР-12637/12.05.2017 |
02.05.2018 |
|
|
Активен |
15714 |
| C07AB02 |
Metoprolol |
Metostad CR |
Prolonged release tablet |
23.75 mg |
(съответстващ на 25 mg metoprolol tartrate) |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
7.42 |
0.225 |
1.13 |
50% |
0.56 |
За I11.0 и I11.9 да се отпуска само за деца и юноши от 6 до 18 години. |
I11.0,I11.9,I50.0,I50.1 |
НСР-12636/12.05.2017; КП-20/22.03.2018 и НСР-14544/30.11.2017 |
02.05.2018 |
|
|
Активен |
15715 |
| C07AB02 |
Metoprolol |
Promerol |
Film coated tablet |
100 |
mg |
30 |
Софарма АД, България |
150 |
mg |
- |
9.28 |
0.225 |
4.5 |
50% |
2.25 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48 |
НСР-15436/19.04.2018 |
02.06.2018 |
|
|
Активен |
16097 |
| C07AB02 |
Metoprolol |
Promerol |
Film coated tablet |
50 |
mg |
30 |
Софарма АД, България |
150 |
mg |
- |
4.63 |
0.225 |
2.25 |
50% |
1.12 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48 |
НСР-15436/19.04.2018 |
02.06.2018 |
|
|
Активен |
16096 |
| C07AB02 |
Metoprolol |
Succiprol |
Prolonged release tablet |
47.5 mg (съответстващ на 50 mg metoprolol tartrate) |
|
60 |
Teva B.V., Нидерландия |
150 |
mg |
- |
10.54 |
0.225 |
4.5 |
50% |
2.25 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48,I50.0,I50.1 |
НСР-4584/15.09.2014; НСР-17084/26.10.2018; НСР-17441/06.12.2018 |
02.01.2019 |
|
|
Активен |
3169 |
| C07AB02 |
Metoprolol |
Succiprol |
Prolonged release tablet |
95 mg (съответстващ на 100 mg metoprolol tartrate) |
|
60 |
Teva B.V., Нидерландия |
150 |
mg |
- |
15.4 |
0.225 |
9 |
50% |
4.5 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48,I50.0,I50.1 |
НСР-4585/15.09.2014; НСР-17084/26.10.2018; НСР-17325/22.11.2018 |
02.01.2019 |
|
|
Активен |
3168 |
| C07AB02 |
Metoprolol |
Vasocardin 100 |
Tablet |
100 |
mg |
30 |
Zentiva a.s., Словакия |
150 |
mg |
- |
4.18 |
0.209 |
4.18 |
50% |
2.09 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I10,I11,I12,I13,I20,I45.6,I47.1,I48 |
НСР-1357/07.10.2013 |
02.11.2013 |
08.09.2012 |
|
Заличен |
277 |
| C07AB02 |
Metoprolol |
Vasocardin 50 |
Tablet |
50 |
mg |
30 |
Zentiva a.s., Словакия |
150 |
mg |
- |
2.99 |
0.209 |
2.09 |
50% |
1.05 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I10,I11,I12,I13,I20,I45.6,I47.1,I48 |
НСР-1356/07.10.2013 |
02.11.2013 |
08.09.2012 |
|
Заличен |
276 |
| C07AB02 |
Metoprolol 100% |
C07AB02 Metoprolol 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C07AB02 |
Metoprolol |
BETABLOCKADE |
Prolonged release tablet |
100 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
150 |
mg |
8.88 |
- |
0.1895 |
3.79 |
100% |
3.79 |
|
I10 |
HCP-8745/13.04.2016; НСР-18110/07.03.2019 |
02.08.2019 |
08.09.2012 |
|
Активен |
2952 |